M.D. Anderson Cancer Center: Carcinoma trials

The registry lists 112 Carcinoma studies with M.D. Anderson Cancer Center as lead sponsor. 3 are open to participants now and 56 have results posted.

Early Phase 1 6Phase 1 31Phase 2 67Phase 3 3Phase 4 1No phase 17(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the CervixStatus unknownNCT01606293
• Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
• Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT01427205Phase 2
• Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01176604Not applicable
• Sexual Behavior in Head and Neck Cancer PatientsStatus unknownNCT00662662
• Axillary Reverse Mapping for Invasive Carcinoma of the BreastCompletedNCT00645541Phase 1
• Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaTerminatedNCT00354523Phase 1/2
• Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractCompletedNCT00353015Phase 2
• Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following SurgeryCompletedNCT00254384Phase 1
• Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00113347Phase 1
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077142Phase 1/2